Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (2580)	10/31/1997 12:27:00 PM
From: Izzy	Respond to of 6136

In 1997, so far, there has been a 57% decrease in hospital days for those patients taking combo treatment; annual savings of 20-30% even tho' the new drugs cost approx $18,000/yr. Medication noncompliance is directly related to inability to pay for medical care and medications. States have different HIV drug treatment programs (re: Medicaid). There is an attempt being made to segregate HIV patients into "Special Needs Programs." IMO, I don't understand why there is not uniformity in all states in regards to HIV management and why all FDA approved antiretroviral drugs, including Viracept, are not approved and prescribed. Philosphical issues.